Cut Down on Oncology Drug Waste With Better Forecasting

Billions of dollars’ worth of cancer drugs are discarded each year. Manufacturers must refund Medicare for some of this waste. A data-driven approach offers a practical path to greater efficiency.

Scroll to Top